Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-414301Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-445901Peak area normalizedmale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-489449Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-496262Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-498481Peak area normalizedmale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-507903Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-508488Peak area normalizedmale pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-510134Peak area normalizedfemale normoglycemic Neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-511685Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-524727Peak area normalizedfemale normoglycemic no neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-539032Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-542977Peak area normalizedmale pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-561462Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M+CL)-578330Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M-H)-154352Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M-H)-154376Peak area normalizedmale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M-H)-167204Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M-H)-170644Peak area normalizedmale pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M-H)-177578Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M-H)-178567Peak area normalizedmale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M-H)-180137Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M-H)-180255Peak area normalizedmale pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M-H)-184460Peak area normalizedfemale normoglycemic Neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M-H)-185701Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M-H)-192657Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M-H)-193986Peak area normalizedfemale normoglycemic no neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M-H)-203536Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (M-H)-211061Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (M+H)+1938437Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (M+H)+1959655Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (M+H)+1967072Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (M+H)+1988262Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (M+H)+1998307Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (M+H)+2002556Peak area normalizedfemale normoglycemic Neuropathy
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (M+H)+2011879Peak area normalizedmale diabetic no neuropathy
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (M+H)+2012530Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (M+H)+2014024Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (M+H)+2021465Peak area normalizedmale pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (M+H)+2024307Peak area normalizedfemale normoglycemic no neuropathy
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (M+H)+2036142Peak area normalizedmale pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (M+H)+2037226Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODEZEATIN [ISTD] (M+H)+2041717Peak area normalizedmale diabetic Neuropathy

Return to search page
  logo